N

Nykode Therapeutics AS
NYKD

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
NOK756.93M
EV
NOK80.27M
Shares Outstanding
326.55M
Beta
1.16
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
1
P/E 2025E
-
P/Revenue 2025E
124.16x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Nykode Therapeutics AS

gainify

N

Nykode Therapeutics AS

NYKD

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer, autoimmune, and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoant...

Sector

Healthcare

Industry

Biotechnology

CEO

Engsig, Michael

Employees

68

Website

nykode.com

IPO Date

2020-10-07

Headquarters

Oslo Research Park, Gaustadalleen 21, Oslo, Oslo, 0349, Norway

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.